China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData Read more
Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData Read more
India has robust manufacturing capability with sufficient skilled manpower to foster innovation Read more
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData Read more
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData Read more